Gianni Bonadonna
#100,437
Most Influential Person Now
Gianni Bonadonna's AcademicInfluence.com Rankings
Gianni Bonadonnamedical Degrees
Medical
#1147
World Rank
#1458
Historical Rank
Oncology
#47
World Rank
#50
Historical Rank
Gianni Bonadonnaphilosophy Degrees
Philosophy
#3900
World Rank
#6219
Historical Rank
Logic
#1488
World Rank
#2253
Historical Rank
Download Badge
Medical Philosophy
Gianni Bonadonna's Degrees
- Doctorate Medicine University of Milan
Why Is Gianni Bonadonna Influential?
(Suggest an Edit or Addition)Gianni Bonadonna's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- A predictive model for aggressive non-Hodgkin's lymphoma. (1993) (4400)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Combination chemotherapy as an adjuvant treatment in operable breast cancer. (1976) (1273)
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. (1995) (1010)
- Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women (1988) (842)
- Dose-response effect of adjuvant chemotherapy in breast cancer. (1981) (742)
- Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP (1975) (657)
- GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION (1989) (651)
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials (2018) (614)
- Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. (1990) (614)
- Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute. (1998) (570)
- Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. (1991) (558)
- Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans. (1995) (544)
- Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. (1989) (520)
- High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. (1997) (504)
- Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients (1978) (457)
- Phase II evaluation of adriamycin in human neoplasia (1973) (400)
- Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year results. (1995) (396)
- ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned. (2011) (367)
- Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. (1987) (363)
- Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. (1986) (354)
- Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. (1985) (353)
- ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. (2004) (310)
- Second acute leukemia and other malignancies following treatment for Hodgkin's disease. (1986) (302)
- Phase I and preliminary phase II evaluation of adriamycin (NSC 123127). (1970) (292)
- Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer. (1997) (270)
- Adriamycin cardiotoxicity: a survey of 1273 patients. (1979) (256)
- 30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study (2005) (251)
- The CMF program for operable breast cancer with positive axillary nodes: Updated analysis on the disease‐free interval, site of relapse and drug tolerance (1977) (247)
- Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease. (1982) (236)
- Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study. (2000) (233)
- Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy (2005) (229)
- Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial. (2003) (223)
- Clinical Evaluation of Adriamycin, a New Antitumour Antibiotic (1969) (201)
- Alternating drug combinations in the treatment of advanced Hodgkin's disease. (1982) (200)
- Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results. (1997) (195)
- Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles. (1983) (195)
- Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. (1980) (194)
- Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer. (2009) (192)
- Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. (1990) (190)
- Second malignancies in Hodgkin's disease: a complication of certain forms of treatment. (1980) (186)
- Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. (1997) (184)
- Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoietic stem cells for autransplantation. (1989) (184)
- Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. (2006) (184)
- Natural history and survival of inoperable breast cancer treated with radiotherapy and radiotherapy followed by radical mastectomy (1976) (182)
- Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation. (2001) (170)
- Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes. (1991) (166)
- Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results. (1996) (165)
- Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion (2000) (160)
- Multimodal treatment for locally advanced breast cancer. Result of chemotherapy-radiotherapy versus chemotherapy-surgery. (1981) (158)
- Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables. (2001) (157)
- Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer. (1989) (157)
- Drugs ten years later: epirubicin. (1993) (155)
- Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy (2005) (152)
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer (2004) (151)
- A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma (1982) (151)
- Proposal for a new model of breast cancer metastatic development. (1997) (150)
- Testicular dysfunction in Hodgkin's disease before and after treatment. (1991) (146)
- Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. (1992) (137)
- Labeling index as a prognostic marker in non-Hodgkin's lymphomas. (1981) (137)
- Clinical, radiologic, and histopathologic studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125066). (1972) (135)
- Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease. (1982) (134)
- Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes. (1991) (129)
- Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo‐radiotherapy? (1989) (128)
- Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma. (1999) (127)
- Adjuvant systemic therapy for resectable breast cancer. (1985) (126)
- Does surgery modify growth kinetics of breast cancer micrometastases? (2001) (124)
- Cardiac toxicity of daunorubicin. (1969) (124)
- Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. (1993) (119)
- Response and survival in advanced breast cancer after two non-cross-resistant combinations. (1976) (118)
- Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. (2000) (116)
- Evolving concepts in the systemic adjuvant treatment of breast cancer. (1992) (115)
- ABVD chemotherapy in the treatment of Hodgkin's disease. (1982) (114)
- Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients (2004) (114)
- Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5‐fluorouracil for advanced breast cancer (1975) (112)
- A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. (1982) (110)
- Local recurrences following mastectomy: support for the concept of tumor dormancy. (1994) (108)
- Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the Breast (1993) (107)
- BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens. (2002) (107)
- The Non-Hodgkin Lymphoma Pathologic Classification Project. Long-term follow-up of 1153 patients with non-Hodgkin lymphomas. (1988) (107)
- HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer. (2003) (106)
- Primary chemotherapy in operable breast cancer. (1996) (105)
- Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer. (1994) (104)
- Are surgical adjuvant trials altering the course of breast cancer? (1978) (104)
- Chemotherapy of breast cancer: current views and results. (1983) (103)
- Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer. (1994) (103)
- CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome. (2002) (101)
- Malignant Lymphomas of Waldeyer's Ring: Natural History and Survival after Radiotherapy (1972) (100)
- Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process. (2005) (99)
- Phase II study of doxorubicin versus epirubicin in advanced breast cancer. (1986) (97)
- Diffuse large-cell lymphoma of the testis. (1999) (97)
- Cell kinetics as a prognostic indicator in node-negative breast cancer. (1989) (95)
- Multimodal treatment in operable breast cancer: five-year results of the CMF programme. (1981) (92)
- Clinical trials with bleomycin in lymphomas and in solid tumors. (1972) (91)
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer (2005) (87)
- Computer simulation of a breast cancer metastasis model (1997) (87)
- Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease. (1994) (84)
- Preferential sites of involvement and spread in maignant lymphomas. (1968) (83)
- Current status of Milan adjuvant chemotherapy trials for node-positive and node-negative breast cancer. (1986) (83)
- Comparison of Different Trials of Adjuvant Chemotherapy in Stage II Breast Cancer Using a Natural History Data Base (1987) (82)
- Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture. (1982) (82)
- Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. (2003) (81)
- European Cooperative Trial in Operable Breast Cancer (ECTO): Improved freedom from progression (FFP) from adding paclitaxel (T) to doxorubicin (A) followed by cyclophosphamide methotrexate and fluorouracil (CMF) (2005) (80)
- High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. (1994) (79)
- Conservation surgery after primary chemotherapy in large carcinomas of the breast. (1993) (79)
- Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells. (1990) (78)
- Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience. (1991) (76)
- CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease. (1986) (75)
- Combined testicular and foot lymphangiography in testicular carcinomas. (1966) (74)
- Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials. (1990) (74)
- Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer. (2004) (73)
- High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update. (1993) (71)
- Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease. (1991) (71)
- Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour (2004) (71)
- Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors. (1994) (70)
- Quality of institutional participation in multicenter clinical trials. (1981) (69)
- Second malignancies after CMF for resectable breast cancer. (1987) (68)
- Toxic and Therapeutic Activity of 4'-Epi-Doxorubicin (1982) (67)
- THE EFFECTS OF VARYING DOSAGES OF IRRADIATION UPON STERNAL-MARROW REGENERATION. (1964) (65)
- Clinical Trials with Adriamycin. Results of Three-Years Study (1972) (65)
- Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. (1990) (62)
- The contribution of medicine to the primary treatment of breast cancer. (1988) (61)
- Preliminary phase I study of 4'-epi-adriamycin. (1979) (61)
- Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy (1986) (60)
- Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. (1979) (59)
- Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute. (2005) (58)
- Development and Use of a Natural History Data Base of Breast Cancer Studies (1987) (58)
- Current status of adjuvant chemotherapy for breast cancer. (1987) (58)
- Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy (1990) (57)
- Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP. (1986) (56)
- Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease. (1997) (56)
- Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer. (2003) (55)
- Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease. (1977) (54)
- The value of staging laparotomy in non‐Hodgkin's lymphomas. (With emphasis on the histiocytic type) (1974) (53)
- Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates. (1988) (52)
- Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients. (1992) (52)
- Ten‐year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus (2002) (52)
- 3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer. (1990) (51)
- Role of anthracyclines in the treatment of early breast cancer. (2009) (51)
- Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer. (1997) (51)
- Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience (2000) (50)
- Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy. (1991) (50)
- Lymphoreticular sarcomas with primary involvement of waldeyer's ring. Clinical evaluation of 225 cases (1970) (50)
- Parametric survival analysis of adjuvant therapy for stage II breast cancer (1994) (50)
- Textbook of Breast Cancer: A Clinical Guide to Therapy (1997) (48)
- Cell kinetics as a prognostic marker in locally advanced breast cancer. (1987) (48)
- Urinary hydroxyproline and calcium metabolism in patients with cancer. (1966) (47)
- Preoperative chemotherapy in operable breast cancer (1993) (47)
- Clinical use of adriamycin in advanced testicular cancer. (1972) (46)
- Third-line salvage chemotherapy in Hodgkin's disease. (1985) (45)
- Preliminary clinical experience with 4-epidoxorubicin in advanced human neoplasia. (1980) (45)
- Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II study (2005) (45)
- Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? (1998) (45)
- Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary. (1975) (45)
- Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens. (1984) (44)
- Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience. (1991) (44)
- Tumor grade as a prognostic factor in primary breast cancer. (1989) (44)
- High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery? (1989) (44)
- Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. (1997) (44)
- Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis. (1989) (43)
- Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. (1991) (43)
- Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results. (1982) (43)
- Recent trends in the treatment of non-Hodgkin's lymphomas. (1976) (43)
- ABVD in the treatment of Hodgkin's disease. (1992) (42)
- Vinorelbine: a new promising drug in Hodgkin's disease. (1996) (42)
- Comment to Anderson WF, Jatoi I, Devesa SS: Distinct Breast Cancer Incidence and Prognostic Patterns in the NCI’s SEER Program: Suggesting a Possible Link Between Etiology and Outcome. Breast Cancer Res Treat 90:127–137, 2005 (2006) (42)
- Modern treatment of malignant lymphomas: a multidisciplinary approach? The Kaplan Memorial Lecture. (1994) (42)
- Multimodal therapy with CMF in resectable breast cancer with positive axillary nodes: the Milan Institute experience. (1982) (42)
- Historical Review of Hodgkin's Disease (2000) (42)
- Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors. (1993) (42)
- Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer (2005) (42)
- Elevated Serum Levels of IL-10 are Associated with Inferior Progression-Free Survival in Patients with Hodgkin's Disease Treated with Radiotherapy (2004) (41)
- Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patients. (1992) (41)
- Preliminary 3-year results of 12 versus 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. (1979) (40)
- New anthracycline analogs in advanced breast cancer. (1986) (40)
- ADJUVANT CMF CHEMOTHERAPY IN OPERABLE BREAST CANCER: TEN YEARS LATER (1985) (40)
- Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study. (2000) (40)
- Chemotherapy of malignant lymphomas. (1985) (39)
- Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening. (2004) (39)
- Long‐term effects of therapeutic irradiation upon bone marrow (1964) (39)
- Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances (2011) (39)
- Laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's disease. (1975) (39)
- Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. (1985) (39)
- Sequential pathologic staging of untreated non‐Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy (1977) (38)
- Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy. (1996) (38)
- T3b-T4 breast cancer: factors affecting results in combined modality treatments (1983) (38)
- B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells. (1989) (36)
- Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of ‘cures’ (1999) (36)
- Distribution and excretion of adriamycin in man. (1973) (36)
- Secondary neoplasms in malignant lymphomas after intensive therapy. (1973) (36)
- Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy. (1991) (36)
- Long-term sequelae from adjuvant chemotherapy. (1993) (36)
- Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease. (1999) (36)
- Treatment‐related leukemia in Hodgkin's disease: A multi‐institution study on 75 cases (1987) (35)
- The metabolic effects in man of bovine growth hormone digested with trypsin. (1965) (35)
- Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy. (1988) (34)
- MECHANISM OF ACTION OF ADJUVANT CHEMOTHERAPY IN EARLY BREAST CANCER (1986) (34)
- Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: Different mortality but similar recurrence (2010) (33)
- Patterns of Relapse and Survival in Operable Breast Carcinoma with Positive and Negative Axillary Nodes (1978) (33)
- Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) (2004) (32)
- Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. (1976) (31)
- Adjuvant and neoadjuvant treatment of breast cancer. (2001) (31)
- Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results. (1996) (31)
- BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome. (2002) (31)
- Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy. (1993) (30)
- Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications. (1998) (30)
- Chemotherapy of Advanced Disease (1989) (30)
- Clinical Trials with Adriamycin in Leukemia and Solid Tumors (1969) (30)
- Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata. (1975) (29)
- Systemic therapy in resectable breast cancer. (1989) (28)
- Combined sequential approach in locally advanced breast cancer. (1999) (28)
- Double-Peaked Time Distribution of Mortality for Breast Cancer Patients Undergoing Mastectomy (2002) (28)
- Advances in anthracycline chemotherapy : epirubicin (1984) (27)
- Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation. (1988) (27)
- Mitoxantrone: An Active Agent in Refractory Non‐Hodgkin's Lymphomas (1988) (27)
- Recent trends in the medical treatment of Hodgkin's disease. (1975) (27)
- Malignant Histiocytosis: A Clinicopathologic Study of 18 Consecutive Cases (1978) (26)
- Updated 12-year results of a randomized clinical trial comparing standard-dose to high-dose myeloablative chemotherapy in the adjuvant treatment of breast cancer with more than three positive nodes (LN+) (2007) (26)
- Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. (1992) (26)
- Treatment of advanced malignant melanoma with vinblastine, bleomycin, and cisplatin. (1982) (25)
- Second malignant neoplasms in operable carcinoma of the breast. (1984) (25)
- Phase I study of 4-demethoxydaunorubicin (2004) (24)
- Herpes zoster-varicella infection in malignant lymphomas. Influence of splenectomy and intensive treatment. (1975) (24)
- From adjuvant to neo‐adjuvant chemotherapy in high‐risk breast cancer: The experience of the Milan Cancer Institute. Steiner award lecture 1992 (1993) (24)
- High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease. (2001) (24)
- Improved 5-year survival in advanced Hodgkin's disease by combined modality approach (1979) (23)
- Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease. (1976) (23)
- High-dose medroxyprogesterone acetate in breast cancer resistant to endocrine and cytotoxic therapy (2004) (23)
- The trials of Dr. Bernard Fisher: a European perspective on an American episode. (1997) (23)
- Bleomycin alone and in Combination with Methotrexate in the Treatment of Carcinoma of the Esophagus. (1974) (23)
- Evolution in the treatment strategy of Hodgkin's disease. (1982) (22)
- Chemotherapy of non-Hodgkin's lymphomas (1974) (22)
- Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells. (1988) (21)
- Salvage treatments in relapsing resectable breast cancer. (1989) (21)
- ADJUVANT CHEMOTHERAPY IN BREAST CANCER (1983) (21)
- Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma. (1996) (21)
- Treatment of Metastatic Breast Cancer with Cyclophosphamide, Methotrexate, Vincristine and Fluorouracil. (1973) (21)
- Adriamycin versus adriamycin plus melphalan in advanced ovarian carcinoma. (1977) (20)
- Tamoxifen: A Review of its Pharmacological Properties and Therapeutic Use in the Treatment of Breast Cancer (1978) (20)
- Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer (2001) (20)
- Treatment strategies for Hodgkin's disease. (1988) (20)
- Preliminary clinical screening with adriamycin in lung cancer. (1971) (20)
- LOCAL-REGIONAL RECURRENCE AFTER MASTECTOMY (1976) (20)
- Ten Years Experience with Ewing's Sarcoma (1977) (20)
- Laparoscopy and laparotomy in staging Hodgkin's and non-Hodgkin's lymphoma. (1976) (20)
- Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients (1997) (19)
- Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans. (1989) (19)
- Third-line chemotherapy with CCNU, etoposide and prednimustine (CEP) in Hodgkin's disease (HD) resistant to MOPP and ABVD (1982) (19)
- Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574). (1974) (19)
- Phase I study with 4′ -deoxydoxorubicin (2004) (18)
- Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD. (1989) (18)
- Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease. (1992) (18)
- Combination chemotherapy with adriamycin (NSC-123127) in metastatic mammary carcinoma. (1974) (18)
- Influence of clinical trials on current treatment strategy for Hodgkin's disease. (1990) (17)
- BREASTCAN: an expert system for postoperative breast cancer therapy. (1986) (17)
- Protection studies with sodium thiosulfate against methyl bis (β‐chloroethyllamine hydrochloride (HN2) and its ethylenimonium derivative (1965) (17)
- Advanced breast cancer: are the traditional stratification parameters still of value when patients are treated with combination chemotherapy? (1979) (17)
- Mitomycin C and Vinblastine in Advanced Refractory Breast Cancer (1989) (17)
- Carnitine Kinetics during Dialysis (1985) (17)
- Malignant lymphomas: further studies on their preferential sites of involvement and possible mode of spread. (1969) (17)
- Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas. (1977) (17)
- Comparative effects of vinblastine and procarbazine in advanced Hodgkin's disease. (1969) (17)
- Sequential laparoscopy and laparotomy combined with bone marrow biopsy in staging Hodgkin's disease. (1976) (16)
- Liver Assessment in Women Receiving Adjuvant CMF Chemotherapy 1 (1981) (16)
- Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas. (1977) (16)
- Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan Cancer Institute. (1996) (16)
- Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. (1995) (16)
- Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicity. (1987) (16)
- Controlled Study with Imidazole Carboxamide (DTIC), DTIC + Bacillus Calmette-Guérin (BCG), and DTIC + Corynebacterium Parvum in Advanced Malignant Melanoma (1984) (16)
- Cell proliferation and outcome following doxorubicin plus CMF regimens in node‐positive breast cancer (2000) (15)
- Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease. (1973) (15)
- Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project. (1990) (15)
- Adriamycin as a Single Agent in Various Forms of Advanced Neoplasia of Adults and Children. (1974) (15)
- Re: Dormancy of mammary carcinoma after mastectomy. (2000) (15)
- GM-CSF-exposed peripheral blood progenitors as sole source of stem cells for autologous transplantation in two patients with multiple myeloma. (1990) (15)
- Adjuvant chemoendocrine therapy in breast cancer. (1986) (14)
- Endolymphatic radiotherapy in malignant lymphomas. A clinical evaluation of 285 patients (1968) (14)
- Adjuvant treatment with adriamycin in primary operable osteosarcoma. (1978) (14)
- Non-Hodgkin's Lymphomas of Waldeyer's Ring (1983) (14)
- Combination chemotherapy and combined treatment modality in disseminated and locally advanced breast cancer. (1977) (14)
- Does chemotherapy fulfill its expectations in cancer treatment? (1990) (13)
- Primary chemotherapy for resectable breast cancer. (1993) (13)
- Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I (1979) (13)
- Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer (1996) (13)
- Prognostic factors in Hodgkin's disease: implications for modern treatment (review). (1988) (13)
- Medical Castration with Zoladex: A Conservative Approach to Premenopausal Breast Cancer (1991) (12)
- Evaluation of adjuvant therapy in soft tissue sarcoma. A collaborative multidisciplinary approach. E.O.R.T.C. protocol 62771. (1979) (12)
- Comment on "The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival". (1983) (12)
- Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes (2005) (12)
- Hodgkin's disease and second malignancies. (1993) (12)
- Chemotherapy in prevention of the recurrence of resectable cancer. (1978) (12)
- Estrogen-receptor status and response to chemotherapy in early and advanced breast cancer (1980) (12)
- SPECIFIC EX‐VIVO DEPLETION OF HUMAN BONE MARROW T LYMPHOCYTES BY AN ANTI‐PAN‐T CELL (CD5) RICINA‐CHAIN IMMUNOTOXIN (1987) (12)
- Handbook Of Medical Oncology (1988) (12)
- Classification and Treatment of Hodgkin's Disease (1965) (11)
- MOPP vs MOPP plus ABVD in stage IV Hodgkin's disease (1977) (11)
- Adjuvant CMF chemotherapy in operable breast cancer: Ten years later (1985) (11)
- Breast cancer: Nuclear medicine in diagnosis and therapeutic options (2008) (11)
- Trials of adjuvant chemotherapy in breast cancer. The experience of the Istituto Nazionale Tumori of Milan. (1980) (11)
- Should lymphomas of gastrointestinal tract be treated differently from other disease presentations? (1986) (11)
- Daunomycin Treatment in Chronic Lymphoproliferative Disorders (1968) (11)
- [Preferential sites and methods of diffusion of malignant lymph nodes studied on the basis of 500 cases]. (1967) (11)
- Pathological staging in adult previously untreated non-Hodgkin's lymphomas. (1978) (11)
- Adjuvant Therapies of Cancer (1982) (11)
- Adriamycin plus Bleomycin versus Cyclophosphamide plus Vincristine in Advanced Carcinoma of the Uterine Cervix (1976) (11)
- Cytarabine and cisplatin in advanced malignant melanoma. (1986) (11)
- Methotrexate (NSC-740) and bleomycin (NSC-125066) in the treatment of advanced epidermoid carcinoma of the uterine cervix. (1973) (11)
- Combined modality approach for high-risk breast cancer. The Milan Cancer Institute experience. (1995) (11)
- Combination usage of adriamycin (NSC 123127) in malignant lymphomas (1975) (11)
- Drug selection in the treatment of Hodgkin's disease (2007) (10)
- Staging laparotomy in non-Hodgkin's lymphomata. (1975) (10)
- Lymphangiographic diagnosis of malignant lymphoma (1966) (10)
- Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas. (1992) (10)
- Usefulness of lymphography in childhood neoplasia (1972) (10)
- Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancer. (1991) (10)
- Hodgkin's disease and the risk of acute leukemia in successfully treated patients. (1998) (10)
- Total urinary hydroxyproline excretion in diabetics before and after hypophysectomy and after growth hormone in adult hypopituitarism. (1965) (10)
- The pathologist and the clinical oncologist: a new effective partnership in assessing tumor prognosis. (1989) (10)
- Carboplatin in combination as first-line therapy in advanced breast cancer. (1993) (10)
- Lessons from the initial adjuvant cyclophosphamide, methotrexate, and fluorouracil studies in operable breast cancer. (2008) (10)
- Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma. (1991) (10)
- Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan. (1981) (10)
- Two-dimensional ultrasounds in liver diseases. (1968) (9)
- Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group. (2002) (9)
- Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies. (1998) (9)
- Two-dimensional pulsed echo detection of para-aortic lymph nodes. (1969) (9)
- Practical aspects of flow cytometry to guide large-scale collection of circulating hematopoietic progenitors for autologous transplantation in cancer patients (1992) (9)
- Contribution of prognostic factors to adjuvant chemotherapy in breast cancer. (1984) (9)
- [PROPOSAL OF CLASSIFICATION AND THERAPY OF HODGKIN'S DISEASE]. (1965) (9)
- [Therapy with daunomycin in chronic lymphoproliferative diseases]. (1968) (9)
- Sequential combination chemotherapy in advanced breast cancer (2004) (9)
- Dose-intense adjuvant treatment of high-risk breast cancer. (1990) (9)
- Clinical Staging and Treatment of Lymphosarcoma and Reticulum Cell Sarcoma. (1965) (9)
- Lymphangiography in the diagnosis of retroperitoneal node metastases in rectal cancer. (1967) (9)
- A new prognostic factor in breast cancer. (1977) (9)
- Salvage treatments in Hodgkin's disease. (1991) (8)
- The role of endolymphatic radiotherapy in the treatment of chronic lymphatic leukaemia. (1966) (8)
- [Prognostic factors in breast carcinoma]. (1986) (8)
- VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention. (1996) (8)
- Controversies in the management of gastrointestinal lymphoma (1993) (8)
- Refined measurement of outcome for adjuvant breast carcinoma therapy (2003) (8)
- Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer. (2000) (8)
- Carnitine kinetics during dialysis. Evidence of unilateral transport from tissues to plasma. (1985) (8)
- Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF). (1994) (8)
- [Preliminary study of phase I of bleomycin, a new anti-tumor drug]. (1971) (8)
- Preliminary Phase I Evaluation of Bleomycin, a New Antitumor Antibiotic (1971) (8)
- High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia. (1990) (8)
- The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy. (1992) (8)
- Chemotherapy of testicular tumors. (1971) (8)
- Prognostic factors and response to treatment in non-Hodgkin's lymphomas (review). (1987) (8)
- Adriamycin in Wilms's tumor previously treated with chemotherapy. (1975) (8)
- Small cell carcinoma of the lung: a combined modality treatment. (1979) (8)
- Quantization of CD34+ Peripheral Blood Hematopoietic Progenitors for Autografting in Cancer Patients (1993) (8)
- EXPERT SYSTEMS FOR CANCER CHEMOTHERAPY (1987) (8)
- Adjuvant chemotherapy in breast cancer. (1983) (7)
- [Clinical trial of hydroxyurea in advanced pulmonary carcinoma]. (1967) (7)
- Using a database of protocol studies to evaluate therapy: a breast cancer example. (1984) (7)
- ADJUVANT CHEMOTHERAPY FOR BREAST CANCER (1979) (7)
- Current issues in the management of advanced Hodgkin's disease. (1990) (7)
- Cyclophosphamide, Adriamycin, and cis‐Platinum (CAP) in Metastatic and Locally Advanced Breast Cancer (1988) (7)
- Chemotherapy of lung cancer: the experience of the National Cancer Institute of Milan. (1973) (7)
- Treatment of advanced breast cancer; Workshop report (1983) (7)
- Phase II trial of AMSA in refractory breast cancer. (1982) (7)
- Operable breast cancer: Influence of disease-free and overall survival by adjuvant chemotherapy (CMF) and postoperative radiotherapy (RT) (1978) (7)
- First‐Line Chemotherapy with Intraperitoneal Cisplatin and Intravenous Cyclophosphamide in Ovarian Carcinoma: A Preliminary Report (1989) (7)
- Combination Chemiotherapy with 5-(3,3 dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) and Vincristine (VCR; NSC - 67574) in Metastatic Malignant Melanoma (1973) (7)
- Current results with a combined treatment approach to localized Ewing's sarcoma. (1978) (6)
- Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program. (1977) (6)
- [Preferential sites and methods of diffusion of malignant lymphomas in childhood]. (1968) (6)
- Prospective randomized trial in advanced malignant melanoma with cis‐platinum, vindesine, and etoposide vs. cis‐platinum, vindesine, and lomustine (1985) (6)
- Activity of vinorelbine (VIN) in advanced breast cancer: Preliminary results of a phase II trial (1993) (6)
- Phase II study with amsacrines (m-AMSA and m-AMSA lactate) in refractory lymphomas. (1985) (6)
- Endolymphatic radiotherapy in malignant lymphomas--long term results. (1970) (6)
- Present status of CMF adjuvant therapy in operable breast cancer. (1977) (6)
- Current status of the Milan trials for Hodgkin’s disease in adults (1985) (6)
- Introduction: management of hormone-responsive tumors. (1983) (6)
- Clinical Evaluation of High Weekly Intravenous Doses of Methotrexate in Advanced Oropharyngeal Carcinoma (1970) (6)
- Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, Italy. (1990) (6)
- Adriamycin in the adjuvant treatment of operable osteosarcoma. (1978) (6)
- Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells. (1994) (6)
- High-risk breast cancer: Therapy (1993) (6)
- Clinical Evaluation of High Intermittent Intravenous Doses of Methotrexate in Advanced Lung Cancer (1969) (6)
- CVP versus BACOP Chemotherapy Sequentially Combined with Irradiation in Stage I–II Diffuse Non-Hodgkin’s Lymphomas (1985) (5)
- Simultaneous diagnosis of Hodgkin's disease and chronic lymphocytic leukemia. (1968) (5)
- Adjuvant chemotherapy for node-negative breast cancer patients. (1989) (5)
- Mitoxantrone as First-Salvage Chemotherapy in Relapsed Breast Cancer (1989) (5)
- What did we learn from the results of the international overview about the effects of endocrine therapy? (1993) (5)
- Aminoglutethimide in Postmenopausal Breast Cancer Refractory to Multiple Hormonal and Cytostatic Treatments (1987) (5)
- Controlled studies with bleomycin in solid tumors and lymphomas. (1976) (5)
- Late Relapse in Hodgkin Lymphoma (HL): A Retrospective Analysis of Patients Enrolled on Clinical Trials at the Istituto Nazionale Tumori of Milan (INT-MI) (2015) (5)
- Therapeutic and toxicologic effects of MOPP vs ABVD when combined with RT in Hodgkin's disease (1981) (5)
- Combined modality management of operable breast cancer. (1978) (5)
- Combined chemotherapy-radiotherapy approach in stages IIB, IIIA and IIIB Hodgkin's disease (1977) (5)
- A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome. (1995) (5)
- [Microcalcifications in the diagnosis and follow-up after the primary chemotherapy of breast neoplasms]. (1992) (5)
- Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF). (1990) (5)
- Breast cancer : diagnosis and management (1984) (5)
- Treatment of residual neoplastic disease in solid tumours. (1976) (5)
- Lymphography in Childhood Cancer (1972) (4)
- [Primary chemotherapy in operable breast carcinoma]. (1999) (4)
- Adjuvant therapies of the various primary tumors (1979) (4)
- Role of chemotherapy in stage I breast cancer. (1989) (4)
- Adjuvant castration versus adjuvant chemotherapy. (1978) (4)
- Pilot Study with Adriamycin and Ifosfamide in Small Cell Lung Cancer (1989) (4)
- Clinical Evaluation of 4′-Epi Doxorubicin and 4-Demethoxy Daunorubicin (1982) (4)
- Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil for Breast Cancer (1995) (4)
- [Proposal of classification and therapeutic criteria of lymphosarcoma and reticulosarcoma]. (1965) (4)
- Distribution of tritiated daunomycin in man by a simplified method. (1970) (4)
- CMF adjuvant programs at the Milan Cancer Institute. (1984) (4)
- Soft tissue and bone sarcomas. (1994) (4)
- Single Agent Sequential Chemotherapy in Non-Hodgkin's Lymphomas (1973) (4)
- Surgery versus primary chemotherapy plus surgery in squamous cell carcinoma of the oral cavity: Preliminary report of a randomized study (1993) (4)
- Adjuvant chemotherapy in node-negative breast cancer. NCI consensus conference. (1990) (3)
- Adjuvant combination chemotherapy with CMF in primary mammary carcinoma (1977) (3)
- Fertility in young patients treated with chemotherapy for Hodgkin’s disease (HD): Long-term results (2005) (3)
- Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study. (1996) (3)
- Will new treatment strategies improve the control of non-Hodgkin's lymphomas? (1994) (3)
- Controlled Pilot Study with Combination Chemotherapy in Testicular Carcinomas (1976) (3)
- Letter: Local-regional recurrence after mastectomy. (1976) (3)
- Detection of occult leukemic cells in the autologous bone marrow graft of a patient with T-cell acute lymphoblastic leukemia by a highly specific and sensitive assay. (1989) (3)
- Introduction: Breast cancer (1986) (3)
- Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme. (1978) (3)
- [Clinical experimentation with intermittent high doses of methotrexate inoropharyngeal carcinoma in advanced stage]. (1970) (3)
- Controlled study with multiple drug combination in advanced breast cancer (1974) (3)
- Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft. (1989) (3)
- The Milan experience with adjuvant chemotherapy in premenopausal breast cancer. (1989) (3)
- Adriamycin in Combination and in Combined Treatment Modalities. (1974) (3)
- [Response and survival after sequential monochemotherapy in malignant lymphocytic and histocytic lymphoma]. (1973) (3)
- Adjuvant therapies of postsurgical minimal residual disease. (1980) (3)
- End points in the analysis of breast cancer survival: relapse versus death from tumor. (1998) (3)
- The Spread of Malignant Lymphomas in Children (1968) (2)
- Randomized trial of adjuvant chemotherapy in osteogenic osteosarcoma: comparison of altering sequential administrations of high doses of adriamycin, methotrexate, and cyclophosphamide with a 6-month administration of high-dose adriamycin followed by a low-dose semicontinuous chemotherapy. EORTC Oste (1978) (2)
- Adjuvant treatment with prolonged CMF (CTX MTX FU) in operable breast cancer with positive axillary nodes. Progress report (1976) (2)
- New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan. (1984) (2)
- [Long-term results and planning of therapy of seminal tumors of the testis]. (1975) (2)
- Surgery and adjuvant chemotherapy in the treatment of operable breast cancer. (1977) (2)
- Present Position of Radical and Palliative Treatment of Malignant Lymphomas (1971) (2)
- Phase I study of 4-demethoxydaunorubicin (dm-DNR) (1982) (2)
- Bronchial Involvement by Hodgkin Disease (1978) (2)
- Cisplatin and Cyclophosphamide in Advanced Ovarian Carcinoma: Activity and Toxicity of an Ambulatory Regimen (1990) (2)
- SURGERY IN ADVANCED BREAST CANCER (1988) (2)
- Recent progress in multimodal therapy for resectable breast cancer. (1981) (2)
- Breast cancer: adjuvant therapy with anthracyclines. (1992) (2)
- Future developments for paclitaxel in the treatment of breast cancer. (1996) (2)
- Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer. (1978) (2)
- Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis. (1989) (2)
- Preferential Sites and Mode of Spread of Hodgkin's Disease and Lymphoreticular Sarcomas on the Basis of Clinical Evaluation of 500 Cases. (1967) (2)
- [Response and survival after sequential chemotherapy in Hodgkin's disease]. (1973) (2)
- Adjuvant programs for postmenopausal women with node-positive breast cancer: preliminary analysis of 5-year results. (1984) (2)
- Combined approach to malignant small round blue cell neoplasms in the adult (1991) (2)
- Survival and Therapeutic Strategy in Germinal Tumors of Testicle. (1975) (2)
- Adjuvant chemotherapy in postmenopausal women: Results of sequential noncross-resistant regimens (1985) (2)
- International Symposium on Hodgkin's disease. Session 3. Diagnostic evaluation and clinical staging. Invited discussion: Value of staging laparotomy with splenectomy. (1973) (2)
- Future developments in adjuvant systemic therapy for high-risk breast cancer. (1996) (2)
- New strategies in cancer chemotherapy (1986) (2)
- Definition, Activity and Training in Medical Oncology (1973) (2)
- The above letter was referred to the authors who respond as follows (1994) (2)
- The logistics of clinical trials. (1978) (1)
- Four cycles of ABVD followed by involved field irradiation (IF-RT) is the treatment of choice for early-stage Hodgkin's disease (HD): 5-year results of a randomized trial (1997) (1)
- Methyl-CCNU (NSCU-95441) versus methyl-CCNU plus cyclophosphamide (NSC-26271) in advanced gastrointestinal cancer. (1975) (1)
- Treating early breast cancer. (1992) (1)
- Treating early breast cancer (1992) (1)
- Salvage chemotherapy (CT) in Hodgkin's disease (HD) failing to primary radiotherapy (RT): MOPP vs adriamycin-containing regimens (ADM-reg) (1982) (1)
- Guidelines to modern treatment of non-Hodgkin's lymphomas. (1987) (1)
- Surgical adjuvant chemotherapy for carcinomas. (1978) (1)
- Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin. (1987) (1)
- Lymphoma: Editorial overview (1990) (1)
- Comment to Jatoi et al. report (2005) (1)
- Long-term results of high-dose chemotherapy (HDCT) supported by hematopoietic circulating (ASCT) or bone marrow (BMT) stem cell autografting as first salvage treatment for refractory or relapsed Hodgkin's lymphoma. (2006) (1)
- The Non-Hodgkin Lymphoma Pathologic Classification Project (2020) (1)
- Phase II study of weekly administration of vinorelbine in heavily pretreated Hodgkin's disease (1993) (1)
- [Clinical and immunological study in plasma-cellular proliferative disorders]. (1967) (1)
- Primary chemotherapy with cisplatin (CDDP) and epirubicin (EPI) plus radiotherapy for advanced nasopharyngeal carcinoma (NPC) (1993) (1)
- Adjuvant Systemic Therapy (1989) (1)
- Phase I study of 4'-epi-adriamycin (epi-ADM) (1979) (1)
- Combined modality therapy for primary gastro-intestinal non-Hodgkin's lymphoma (GI-NHL) (1993) (1)
- [CURRENT VIEWS ON THERAPY OF METASTATIC CANCER OF THE BREAST]. (1964) (1)
- Transitory L-carnitine depletion in rat skeletal muscle by D-carnitine. (1989) (1)
- [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas]. (1967) (1)
- Controlled Study with 1-Phenylalanine Mustard (L-PAM) and 5-Fluorouracil (5-FU) plus or minus Prednisone in Advanced Breast Cancer 1 (1976) (1)
- CHEMOTHERAPY AFTER MASTECTOMY (1976) (1)
- Clinical trials on adjuvant therapies in cancer: short-term and long-term results. (1982) (1)
- Freedom from progression (FFP) by adding paclitaxel (T) to doxorubicin (A) followed by CMF as adjuvant or primary systemic therapy: 10-yr results of a randomized phase III European Cooperative Trial in Operable Breast Cancer (ECTO). (2013) (1)
- Expression of Epstein-Barr Virus Latent Membrane Protein-1 in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin ’ s Lymphoma : Associations with Presenting Features , Serum Interleukin 10 Levels , and Clinical Outcome 1 (2003) (1)
- Establishing minimal institutional patient entry rate requirements for participation in multicenter clinical trials (1980) (1)
- Markers and general problems of cancer adjuvant therapies (1979) (1)
- [Association of endolymphatic radiotherapy and alkylating agents in the treatment of retoperitoneal localizations of malignant lymphomas]. (1966) (1)
- CTX, VCR, PRED (CVP) alternated with ADM, BLM, PRED (ABP) in advanced non-Hodgkin's lymphomas (NHL) (1978) (1)
- Original article: Salvage chemotherapy in Hodgkin's disease (1990) (1)
- Prospects for Doxorubicin in Adjuvant Breast Cancer Trials (1982) (1)
- Individualized therapy of breast cancer: a dream or a reality? (2006) (1)
- Clinical trials in cancer medicine: Past achievements and future prospects (1985) (0)
- 782 Clinical significance of soluble II-2 receptors (S-IL-2R) in hodgkin’s disease (HD) (1995) (0)
- Magnetic resonance staging of hodgkin disease (HD) and non-hodgkin lymphoma (NHL) (1990) (0)
- Four-drug sequential regimen in advanced breast cancer (1987) (0)
- Outcome of very late relapse of Hodgkin's disease (HD) at the National Cancer Institute of Milan (2001) (0)
- Restricted Saporin Immunotoxins : Activity Against B-Cell Lines and Chronic Lymphocytic Leukemia Cells (2005) (0)
- Adjuvant chemotherapy for operable breast cancer: old vs new schema (2005) (0)
- Erratum: Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells (Bone Marrow Transplantation (1994) 14 (863-869)) (1995) (0)
- Soft tissue and bone sarcomas. (1993) (0)
- Degenerative and inflammatory musculoskeletal disorders: updates and hot topics in diagnostic and interventional imaging. (2022) (0)
- P70 5-Year results of combined modality approach in locally advanced breast cancer (LABC). Analysis of prognostic factors (1998) (0)
- Current Studies at the Milan Cancer Institute with Bleomycin-Containing Regimens for Malignant Lymphomas (1982) (0)
- The timing of breast cancer recurrence after mastectomy and adjuvant CMF chemotherapy supports a dormancy-based model for metastatic development (2004) (0)
- 545 Second malignancies (SM) in esophageal cancer (EC) after combined modality treatment: Implications for follow-up and chemoprevention (1995) (0)
- Soft tissue and bone sarcomas. (1992) (0)
- [Evaluation of the pituitary reserve after the introduction of Y90 into the sella turcica]. (1970) (0)
- immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates Synthesis and characterization of an antihuman T-lymphocyte saporin (2013) (0)
- targets of retroviral-mediated gene transfer Human peripheral blood hematopoietic progenitors are optimal (2011) (0)
- 398 Chemotherapy (CT) with radiotherapy (RT): Larynx preservation strategy in cervical squamous cell carcinoma of the esophagus (CSCCE) (1995) (0)
- Breast cancer. (2002) (0)
- Late intensification (LI) after induction chemotherapy (ICT) for stage IIIB small cell lung cancer (SCLC) (1993) (0)
- Clinical Evaluation of Hydroxyurea in Advanced Lung Cancer (1967) (0)
- [Comparative evaluation of the therapeutic effectiveness of vinblastine and of procarbazine in advanced stages of Hodgkin's disease]. (1968) (0)
- Controlled study with L PAM and 5 FU (IV or PO) plus or minus prednisone in advanced breast cancer (1975) (0)
- Gemcitabine i n t he T reatment o f R efractory H odgkin's Disease: R esults o f a M ulticenter P hase I I S tudy (2000) (0)
- [Clinical experimentation with high intermittent doses of methotrexate in advanced lung cancer]. (1969) (0)
- Chromosomes Alterations in a non Neoplastic Lymph Node (1966) (0)
- Prospective randomized trial in the treatment of early stage hodgkin's disease (ESHD) using involved field radiation therapy (IFRT) vs. subtotal nodal irradiation (STNI) after a short chemotherapy (CT) course (2001) (0)
- DI-3. Has primary chemotherapy a routine role? DI-3-1 Yes (1996) (0)
- Effects of adjuvant systemic treatments in breast cancer. (1996) (0)
- [Treatment of bronchopulmonary neoplasms]. (1973) (0)
- Feasibility of an intensive combined approach in advanced Hodgkin's disease (HD) (1993) (0)
- Studies on some endocrine glands and on the gonads of rats (Rattus norvegicus) treated with antibiotics by mouth or parenterally. (1959) (0)
- Combined RT-chemotherapy (CVP vs BACOP) in PS I-II diffuse non-Hodgkin's lymphomas (NHL) (1981) (0)
- Internation workshop on surgical adjuvant antineoplastic chemotherapy in solid tumors. Conclusions and recommendations of the workshop. Clinical and biological background of surgical adjuvant chemotherapy. (1978) (0)
- Current impact of adjuvant chemotherapy in resectable cancer (2004) (0)
- Analgesic and antitussive activity in man of 3-methyl-8-propionyl-3,8-diazabicyclo-[3.2.1]octane, with some comments on experimental design. (1968) (0)
- Primary chemotherapy in surgically resectable breast cancer: the experience of the Milan Cancer Institute. (1996) (0)
- Surgical adjuvant chemotherapy in breast cancer with positive auxillary lymph nodes. (1978) (0)
- [Use of hexoestrol in the therapy of advanced breast carcinoma]. (1970) (0)
- LONG-TERM Risk of Late Effects After Treatment for EARLY-STAGE HODGKIN'S Lymphoma (HL). (2012) (0)
- Textbook of Breast Cancer. A Clinical Guide to Therapy. Martin Dunitz Publishers, Wien/New York/Berlin/Heidelberg (1997) (1998) (0)
- [The useless pain]. (2008) (0)
- The chemotherapy of cancer (1969) (0)
- Adriamycin Used in Combination with Conventional Agents in the Treatment of Solid Tumors (1975) (0)
- Phosphohexose Isomerase Activity in Lymphocyte Cultures from Cancer Patients (1984) (0)
- [Indications and preliminary results of diagnostic laparotomy in various types of malignant lymphoma]. (1971) (0)
- Endolymphatic radiotherapy (ERT) for malignant lymphomas: indications and long-term results. (1970) (0)
- Clinical and Immunological Study in Disproliferative Disorders of Plasmacells (1967) (0)
- Will new treatment strategies improve the control of non‐Hodgkin's lymphomas?: Editorial review (1994) (0)
- Intermediate-high dose sequential single agent chemotherapy combined with irradiation in advanced Hodgkin's disease (HD) (1997) (0)
- Gemcitabine a s a S ingle A gent i n t he T reatment o f R elapsed or R efractory A ggressive N on-Hodgkin's L ymphoma (1999) (0)
- Soft tissue and bone sarcomas. (1988) (0)
- Adjuvant chemotherapy for breast cancer. (1988) (0)
- [Description of a case of vaginal carcinoma associated with Hodgkin's disease]. (1966) (0)
- 93 A new staging system for small cell lung cancer (SCLC): A proposal (1995) (0)
- 12 versus 6 cycles of adjuvant CMF in breast cancer — Reply (1982) (0)
- Soft tissue and bone sarcomas. (1991) (0)
- A new philosophy in breast cancer therapy. (1998) (0)
- Serum IL-10 and progression-free survival in Hodgkins disease patients treated only with radiotherapy (1999) (0)
- [Cytogenetic contribution to clinical and cytologic diagnosis]. (1966) (0)
- Breast Cancer (1989) (0)
- Chapter 14 – NON-HODGKIN'S LYMPHOMAS: MILAN STUDIES (1985) (0)
- Short report Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma (2005) (0)
- Management of breast cancer after childhood cancer and Hodgkin's lymphoma. (2011) (0)
- Peripheral T-cell lymphoma (PTCL): The milan cancer institute experience (1993) (0)
- [Oral gestagen treatment of advanced breast neoplasms with norethisterone acetate]. (1980) (0)
- Small round blue cell malignant tumors of soft tissues and bone in adult patients (1993) (0)
- Introduction (0)
- HER2 O verexpression a nd D oxorubicin i n A djuvant Chemotherapy f or R esectable B reast C ancer (2003) (0)
- Newer anticancer drugs and procedures (1972) (0)
- Chemotherapy in Operable Breast Cancer : Ten Years Later (0)
- Relationship between estrogen receptors and CMF adjuvant chemotherapy. (1984) (0)
- Combined modality treatment in stage I and II diffuse non-Hodgkin's lymphomas. (1985) (0)
- [Current state of chemotherapy of pulmonary carcinoma]. (1983) (0)
- Adjuvant Chemotherapy of Breast Cancer: The Milan Cancer Institute Trials (1986) (0)
- The timing of breast cancer recurrence after mastectomy and adjuvant CMF chemotherapy supports a dormancy-based model for metastatic development. (2004) (0)
- [Determination of zinc protoporphyrins in pregnancy and the puerperium]. (1981) (0)
- [Clinical use of hematopoietic growth factors]. (1991) (0)
- Adjuvant Chemotherapy Programs in Node-Negative Breast Cancer (1991) (0)
- Response and Survival in Hodgkin's Disease after Sequential Chemotheraphy Employing a Single Agent. (1973) (0)
- Primary C hemotherapy i n R esectable O ral C avity S quamous Cell C ancer: A R andomized C ontrolled T rial (2003) (0)
- 43 From adjuvant to neoadjuvant chemotherapy for high-risk breast cancer (1995) (0)
- Primary chemotherapy and surgery in advanced oral cavity squamous cell carcinomas : retrospective analysis (1991) (0)
- Recombinant Human GM-CSF for Large-Scale Collection of Circulating Hematopoietic Progenitors in Cancer Patients Treated with High-Dose Cyclophosphamide (1990) (0)
- Treating early breast cancer. (2000) (0)
- ABVD or equivalent regimens Hodgkin disease predicts a poorer prognosis in patients treated with BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical (2013) (0)
- Textbook of breast cancer (2013) (0)
- 2039 Extension of radiotherapy (involved field vs subtotal nodal) after short-term chemotherapy in early-stage Hodgkin's disease (ESHD) (1995) (0)
- Soft tissue and bone sarcomas. (1996) (0)
- [Adjuvant chemotherapy in breast cancer. New strategies]. (2000) (0)
- Operable Breast Cancer with Positive Axillary Nodes: The Experience of the Milan Cancer Institute (1979) (0)
- 359 Paclitaxel by 3-H on day 1 & 8 every three-weeks in women with anthracycline-resistant metastatic breast cancer (1995) (0)
- Lymphangiogaphic diagnosis of malignant lympnoma. (1966) (0)
- S30 Putting the taxanes to work (1998) (0)
- Soft tissue and bone sarcomas. (1990) (0)
- Breast cancer. (2001) (0)
- Chapter 10 – HODGKIN'S DISEASE: AN OVERVIEW AND ABVD STUDIES IN MILAN (1985) (0)
- Combined radiation and chemotherapy in esophageal cancer. (1993) (0)
- Soft tissue and bone sarcomas. (1987) (0)
- [Pulmonary changes due to bleomycin. Radiologic study]. (1971) (0)
- PREVENTION OF THE RECURRENCE OF RESECTABLE CANCER (1978) (0)
- EDITORIALS Dose-Intense Adjuvant Treatment of High-Risk Breast Cancer (2004) (0)
- Improved 5-year relapse-free and total survival after radiotherapy (RT) and adjuvant CVP chemotherapy in stage I-II non-Hodgkin's lymphomas (NHL) (1979) (0)
- [Intensive therapy of Hodgkin's disease]. (1973) (0)
- A retrospective analysis of 201 nasopharyngeal carcinoma PTS to compare staging classifications (1993) (0)
- Taxane-containing primary chemotherapy for inflammatory breast cancer: INT experience (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gianni Bonadonna?
Gianni Bonadonna is affiliated with the following schools:
